Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer

PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer

Hartkopf, A. D., Taran, F., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,989

Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review

Wanchoo, R., Karam, S., Uppal, N. N., Barta, V. S., Deray, G., Devoe, C., Launay‐Vacher, V., Jhaveri, K. D., & on behalf of Cancer and Kidney International Network Workgroup on Immune Checkpoint Inhibitors (2017) · American Journal of Nephrology · doi:10.1159/000455014 · Cited by 15,320

The blockade of immune checkpoints in cancer immunotherapy

Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838

PD-1 blockade induces responses by inhibiting adaptive immune resistance

Tumeh, P. C., Harview, C. L., Yearley, J. H., Shintaku, I. P., Taylor, E. J. M., Robert, L., Chmielowski, B., Spasic, M., Henry, G., Ciobanu, V., et al. (2014) · Nature · doi:10.1038/nature13954 · Cited by 6,609

Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion

Schreiber, R. D., Old, L. J., & Smyth, M. J. (2011) · Science · doi:10.1126/science.1203486 · Cited by 6,474

Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients

Herbst, R. S., Soria, J.-C., Kowanetz, M., Fine, G. D., Hamid, O., Gordon, M. S., Sosman, J. A., McDermott, D. F., Powderly, J. D., Gettinger, S. N., et al. (2014) · Nature · doi:10.1038/nature14011 · Cited by 5,231

The immune contexture in human tumours: impact on clinical outcome

Fridman, W. H., Pagès, F., Sautès-Fridman, C., & Galon, J. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3245 · Cited by 4,981

Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma

Snyder, A., Makarov, V., Merghoub, T., Yuan, J., Zaretsky, J. M., Desrichard, A., Walsh, L. A., Postow, M. A., Wong, P., Ho, T. S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1406498 · Cited by 4,286

Nivolumab plus Ipilimumab in Advanced Melanoma

Wolchok, J. D., Kluger, H., Callahan, M. K., Postow, M. A., Rizvi, N. A., Lesokhin, A. M., Segal, N. H., Ariyan, C. E., Gordon, R.-A., Reed, K., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1302369 · Cited by 4,230

Molecular and genetic properties of tumors associated with local immune cytolytic activity

Rooney, M. S., Shukla, S. A., Wu, C. J., Getz, G., & Hacohen, N. (2015) · Cell · doi:10.1016/j.cell.2014.12.033 · Cited by 3,825

Diverticular Disease: a Gut Microbiota Perspective

Ticinesi, A., Nouvenne, A., Corrente, V., Tana, C., Mario, F. D., & Meschi, T. (2019) · Journal of Gastrointestinal and Liver Diseases · doi:10.15403/jgld-277 · Cited by 48

The pathogenic oral–gut–liver axis: new understandings and clinical implications

Imai, J., Kitamoto, S., & Kamada, N. (2021) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2021.1935877 · Cited by 46

Contribution of Immunoscore and Molecular Features to Survival Prediction in Stage III Colon Cancer

Sinicrope, F. A., Shi, Q., Hermitte, F., Zemla, T., Mlecnik, B., Benson, A. B., Gill, S., Goldberg, R. M., Kahlenberg, M. S., Nair, S., et al. (2020) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkaa023 · Cited by 43

Interaction between microbiota and immunity and its implication in colorectal cancer

Xing, C., Du, Y., Duan, T., Nim, K., Chu, J., Wang, H. Y., & Wang, R. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.963819 · Cited by 47

Gut Microbiota and Tumor Immune Escape: A New Perspective for Improving Tumor Immunotherapy

He, Y., Huang, J., Li, Q., Xia, W., Zhang, C., Liu, Z., Xiao, J., Yi, Z., Deng, H., Xiao, Z., et al. (2022) · Cancers · doi:10.3390/cancers14215317 · Cited by 47

Patients with mesenchymal tumours and high Fusobacteriales prevalence have worse prognosis in colorectal cancer (CRC)

Salvucci, M., Crawford, N., Stott, K. J., Bullman, S., Longley, D. B., & Prehn, J. H. M. (2021) · Gut · doi:10.1136/gutjnl-2021-325193 · Cited by 42

An overview of yeast probiotics as cancer biotherapeutics: possible clinical application in colorectal cancer

Shamekhi, S., Lotfi, H., Abdolalizadeh, J., Bonabi, E., & Zarghami, N. (2020) · Clinical & Translational Oncology · doi:10.1007/s12094-019-02270-0 · Cited by 44

Exploring the Inflammatory Pathogenesis of Colorectal Cancer

Khalyfa, A. A., Punatar, S., Aslam, R., & Yarbrough, A. (2021) · Diseases · doi:10.3390/diseases9040079 · Cited by 44

Identification of a novel gut microbiota signature associated with colorectal cancer in Thai population

Iadsee, N., Chuaypen, N., Techawiwattanaboon, T., Jinato, T., Patcharatrakul, T., Malakorn, S., Petchlorlian, A., Praditpornsilpa, K., & Patarakul, K. (2023) · Scientific Reports · doi:10.1038/s41598-023-33794-9 · Cited by 45

A Comprehensive Overview of Colon Cancer- A Grim Reaper of the 21st Century

Kumar, R., Harilal, S., Carradori, S., & Mathew, B. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666201026143757 · Cited by 44

Emerging Role of Immunotherapy for Colorectal Cancer with Liver Metastasis

Yu, X., Zhu, L., Liu, J., Xie, M., Chen, J., & Li, J. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s271955 · Cited by 43

The triple interactions between gut microbiota, mycobiota and host immunity

Yang, J., Yang, H., & Li, Y. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2094888 · Cited by 44

Interactions between extracellular vesicles and microbiome in human diseases: New therapeutic opportunities

Luo, R., Chang, Y., Liang, H., Zhang, W., Song, Y., Li, G., & Cao, Y. (2023) · iMeta · doi:10.1002/imt2.86 · Cited by 41

The Gut Microbiome Advances Precision Medicine and Diagnostics for Inflammatory Bowel Diseases

Mousa, W. K., & Ali, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252011259 · Cited by 50

Fusobacterium Nucleatum-Induced Tumor Mutation Burden Predicts Poor Survival of Gastric Cancer Patients

Hsieh, Y., Kuo, W.-L., Hsu, W.-T., Tung, S., & Li, C. (2022) · Cancers · doi:10.3390/cancers15010269 · Cited by 38

Oral Pathogens’ Substantial Burden on Cancer, Cardiovascular Diseases, Alzheimer’s, Diabetes, and Other Systemic Diseases: A Public Health Crisis—A Comprehensive Review

Murray, P. E., Coffman, J. A., & Garcı́a-Godoy, F. (2024) · Pathogens · doi:10.3390/pathogens13121084 · Cited by 46

Oral microbiota and gastrointestinal cancer

Zhang, Y., Niu, Q., Fan, W., Huang, F. P., & He, H. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s194153 · Cited by 39

Therapeutic potential of melatonin in colorectal cancer: Focus on lipid metabolism and gut microbiota

Pan, S., Guo, Y., Hong, F., Xu, P., & Zhai, Y. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166281 · Cited by 37

Chr20q Amplification Defines a Distinct Molecular Subtype of Microsatellite Stable Colorectal Cancer

Zhang, B., Yao, K., Zhou, E., Zhang, L., & Cheng, C. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-4009 · Cited by 36

Fusobacterium nucleatum, the communication with colorectal cancer

Luo, K., Zhang, Y., Xv, C., Ji, J., Lou, G., Guo, X., Chen, M., Zhang, Y., Wei, H., Guo, M., et al. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108988 · Cited by 38

Increasing Fusobacterium infections with Fusobacterium varium, an emerging pathogen

Lee, S. J., Baek, Y. J., Kim, J. N., Lee, K. H., Lee, E. H., Yeom, J., Choi, J. Y., Ku, N. S., Ahn, J. Y., Kim, J. H., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0266610 · Cited by 36

Exploring the microbiota to better understand gastrointestinal cancers physiology

Panebianco, C., Potenza, A., Andriulli, A., & Pazienza, V. (2018) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2017-1163 · Cited by 46

FadA-positive Fusobacterium nucleatum is prevalent in biopsy specimens of Iranian patients with colorectal cancer

Kashani, N., Abadi, A. T. B., Rahimi, F., & Forootan, M. (2020) · New Microbes and New Infections · doi:10.1016/j.nmni.2020.100651 · Cited by 37

Metagenomic Analyses Expand Bacterial and Functional Profiling Biomarkers for Colorectal Cancer in a Hainan Cohort, China

Chang, H., Mishra, R., Cen, C., Tang, Y., Ma, C., Wasti, S., Wang, Y., Ou, Q., Chen, K., & Zhang, J. (2021) · Current Microbiology · doi:10.1007/s00284-020-02299-3 · Cited by 35

Salivary Microbiota Composition in Patients with Oral Squamous Cell Carcinoma: A Systematic Review

Mauceri, R., Coppini, M., Vacca, D., Bertolazzi, G., Panzarella, V., Fede, O. D., Tripodo, C., & Campisi, G. (2022) · Cancers · doi:10.3390/cancers14215441 · Cited by 35

Iron accelerates Fusobacterium nucleatum–induced CCL8 expression in macrophages and is associated with colorectal cancer progression

Yamane, T., Kanamori, Y., Sawayama, H., Yano, H., Nita, A., Ohta, Y., Hinokuma, H., Maeda, A., Iwai, A., Matsumoto, T., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.156802 · Cited by 33

Gut microbiota interactions with antitumor immunity in colorectal cancer: From understanding to application

Zhuang, Y.-P., Zhou, H., Chen, H., Zheng, M.-Y., Liang, Y., Gu, Y.-T., Li, W., Qiu, W., & Zhou, H. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115040 · Cited by 34

An Overview of Gut Microbiota and Colon Diseases with a Focus on Adenomatous Colon Polyps

Pop, O. L., Vodnar, D. C., Diaconeasa, Z. M., Istrati, M., Bințințan, A., Bintintan, V. V., Suharoschi, R., & Gabbianelli, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197359 · Cited by 34

The Composition of Colonic Commensal Bacteria According to Anatomical Localization in Colorectal Cancer

Zhao, L., Zhang, X., Zuo, T., & Yu, J. Q. (2017) · Engineering · doi:10.1016/j.eng.2017.01.012 · Cited by 35

Altered Gut Microbiota in Patients With Peutz-Jeghers Syndrome

Wan, S., Huang, G., Wang, J.-X., Tian, L., Zuo, X., Li, Y., & Yu, Y. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.881508 · Cited by 31

Study Insights into Gastrointestinal Cancer through the Gut Microbiota

Kong, F., & Cai, Y. (2019) · BioMed Research International · doi:10.1155/2019/8721503 · Cited by 33

The oral-gut-circulatory axis: from homeostasis to colon cancer

Tortora, S. C., Agurto, M. I. G., & Martello, L. A. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1289452 · Cited by 34

Tumor Potentiating Mechanisms of Fusobacterium nucleatum , A Multifaceted Microbe

Holt, R. A., & Cochrane, K. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.01.024 · Cited by 31

Multifaceted Impacts of Periodontal Pathogens in Disorders of the Intestinal Barrier

Liu, Y., Huang, W., Wang, J., Ma, J., Zhang, M., Lü, X., Liu, J., & Kou, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.693479 · Cited by 34

EnsDeepDP: An Ensemble Deep Learning Approach for Disease Prediction Through Metagenomics

Shen, Y., Zhu, J., Deng, Z., Lu, W., & Wang, H. (2022) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2022.3201295 · Cited by 32

Tumor-resident microbes: the new kids on the microenvironment block

Li, L., Chandra, V., & McAllister, F. (2024) · Trends in Cancer · doi:10.1016/j.trecan.2023.12.002 · Cited by 30

The Gastric Microbiome and Its Influence on Gastric Carcinogenesis

Zhang, C., Powell, S. E., Betel, D., & Shah, M. A. (2017) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2017.01.002 · Cited by 30

Relationship of the mucosal microbiota to gastrointestinal inflammation and small cell intestinal lymphoma in cats

Garraway, K., Johannes, C. M., Bryan, A., Peauroi, J. R., Rossi, G., Zhang, M., Wang, C., Allenspach, K., & Jergens, A. E. (2018) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.15291 · Cited by 30

Alterations of the Oral Microbiota Profiles in Chinese Patient With Oral Cancer

Li, Z., Chen, G., Wang, P., Sun, M., Zhao, J., Li, A., & Sun, Q. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.780067 · Cited by 30

Macrophage Phenotype in Combination with Tumor Microbiome Composition Predicts RCC Patients’ Survival: A Pilot Study

Kovaleva, O. V., Алексеевна, П. П., Sorokin, M., Mochalnikova, V. V., Kataev, V., Khlopko, Y. A., Plotnikov, A. O., Stilidi, I. S., Кушлинский, Н. Е., & Gratchev, A. N. (2022) · Biomedicines · doi:10.3390/biomedicines10071516 · Cited by 30

Association of tumor-infiltrating lymphocytes with survival depends on primary tumor sidedness in stage III colon cancers (NCCTG N0147) [Alliance]

Saberzadeh-Ardestani, B., Foster, N. R., Lee, H. E., Shi, Q., Alberts, S. R., Smyrk, T. C., & Sinicrope, F. A. (2022) · Annals of Oncology · doi:10.1016/j.annonc.2022.07.1942 · Cited by 31

The Impact of the Gut Microbiome on Colorectal Cancer

Maisonneuve, C., Irrazábal, T., Martín, A., Girardin, S. E., & Philpott, D. J. (2017) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030617-050240 · Cited by 30

Characterization of Mucosal Dysbiosis of Early Colonic Neoplasia

Hong, B., Ideta, T., Lemos, B. S., Igarashi, Y., Tan, Y., DiSiena, M., Mo, A., Birk, J. W., Forouhar, F., Devers, T. J., et al. (2019) · npj Precision Oncology · doi:10.1038/s41698-019-0101-6 · Cited by 33

Impact of Fusobacterium nucleatum in the gastrointestinal tract on natural killer cells

Kim, Y. J., Kim, B. K., Park, S. J., & Kim, J. H. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i29.4879 · Cited by 31

Immunogenicity of a Fap2 peptide mimotope of Fusobacterium nucleatum and its potential use in the diagnosis of colorectal cancer

Guevarra, L. A., Afable, A. C. F., Belza, P. J. O., Dy, K. J. S., Lee, S. J. Q., Sy-Ortin, T., & Albano, P. M. (2018) · Infectious Agents and Cancer · doi:10.1186/s13027-018-0184-7 · Cited by 29

Interplay between Microbiota and γδ T Cells: Insights into Immune Homeostasis and Neuro-Immune Interactions

Mohamed, A. A. A., al-Ramadi, B. K., & Fernández-Cabezudo, M. J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031747 · Cited by 31

Clinicopathological and prognostic significance of Fusobacterium nucleatum infection in colorectal cancer: a meta-analysis

Huangfu, S., Zhang, W.-B., Zhang, H., Yang, L., Zhang, Y., Nie, J.-L., Chu, X., Chen, C.-S., Jiang, H., & Pan, J. (2021) · Journal of Cancer · doi:10.7150/jca.50111 · Cited by 29

Exploring the interplay between Fusobacterium nucleatum with the expression of microRNA, and inflammatory mediators in colorectal cancer

Bostanghadiri, N., Razavi, S., Shariati, A., Talebi, M., Mirkalantari, S., Razavi, À. E., & Darban‐Sarokhalil, D. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1302719 · Cited by 27

Fusobacterium nucleatum modulates the Wnt/β-catenin pathway in colorectal cancer development

Mondal, T., Chattopadhyay, D., Mondal, P. S., Das, S., Mondal, A., Das, A., Samanta, S., & Saha, T. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.140196 · Cited by 27

Comparison of clinicopathological parameters, prognosis, micro-ecological environment and metabolic function of Gastric Cancer with or without Fusobacterium sp. Infection

Nie, S., Wang, A., & Yuan, Y. (2020) · Journal of Cancer · doi:10.7150/jca.50918 · Cited by 28

Emulating interactions between microorganisms and tumor microenvironment to develop cancer theranostics

Jiang, T., Yang, T., Chen, Y., Miao, Y., Xu, Y., Jiang, H., Yang, M., & Mao, C. (2022) · Theranostics · doi:10.7150/thno.70719 · Cited by 31

Exploring the Potential of Oral Microbiome Biomarkers for Colorectal Cancer Diagnosis and Prognosis: A Systematic Review

Negruț, R. L., Coțe, A., & Maghiar, A. M. (2023) · Microorganisms · doi:10.3390/microorganisms11061586 · Cited by 28

Colorectal Cancer at the Crossroads: The Good, the Bad, and the Future of Platinum-Based Drugs

Kee, J. X., Yau, J. N. N., Muthuramalingam, R. P. K., Wang, X., Chng, W. H., Lopez‐Sanchez, A., Tay, K. K. W., Deng, L., Gibson, D., Bertrand, H. C., et al. (2025) · Chemical Reviews · doi:10.1021/acs.chemrev.5c00041 · Cited by 29

Compositional Shift of Oral Microbiota Following Surgical Resection of Tongue Cancer

Kageyama, S., Nagao, Y., Ma, J., Asakawa, M., Yoshida, R., Takeshita, T., Hirosue, A., Yamashita, Y., & Nakayama, H. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.600884 · Cited by 25

Fusobacterium Nucleatum Is a Risk Factor for Metastatic Colorectal Cancer

Chen, W., Zhang, X., Zhang, Y.-P., Yue, C.-B., Wang, Y.-L., Pan, H., Zhang, Y., Liu, H., & Zhang, Y. (2022) · Current Medical Science · doi:10.1007/s11596-022-2597-1 · Cited by 26

Implication of gut microbes and its metabolites in colorectal cancer

Kumar, A., Ali, A., Kapardar, R. K., Dar, G. M., Nimisha, Apurva, A., Sharma, A. K., Verma, R., Sattar, R. S. A., Ahmad, E., et al. (2022) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-022-04422-2 · Cited by 26

Probiotics formulation and cancer nanovaccines show synergistic effect in immunotherapy and prevention of colon cancer

Xu, X., Zhang, M., Liu, X., Chai, M., Diao, L., Ma, L., Nie, S., Xu, M., Wang, Y., Mo, F., et al. (2023) · iScience · doi:10.1016/j.isci.2023.107167 · Cited by 25

Could Periodontal Disease through Periopathogen Fusobacterium nucleatum Be an Aggravating Factor for Gastric Cancer?

Șurlin, P., Nicolae, F. M., Şurlin, V., Pătrașcu, Ș., Ungureanu, B. S., Didilescu, A. C., & Gheonea, D. I. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9123885 · Cited by 25

Characterization of Chilean patients with sporadic colorectal cancer according to the three main carcinogenic pathways: Microsatellite instability, CpG island methylator phenotype and Chromosomal instability

Wielandt, A. M., Hurtado, C., Mauricio Moreno, C., Villarroel, C., Castro, M., Estay, M., Simian, D., Martínez, M., Vial, M. T., Kronberg, U., et al. (2020) · Tumor Biology · doi:10.1177/1010428320938492 · Cited by 24

Microbe-Driven Genotoxicity in Gastrointestinal Carcinogenesis

Hartl, K., & Sigal, M. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207439 · Cited by 24

Periodontal and Other Oral Bacteria and Risk of Lung Cancer in the Atherosclerosis Risk in Communities (ARIC) Study

Zhou, B., Lu, J., Beck, J. D., MOSS, K. L., Prizment, A. E., Demmer, R. T., Rodriguez, K. A. P., Joshu, C. E., Michaud, D. S., & Platz, E. A. (2022) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-22-0601 · Cited by 24

CT-Based Radiomics to Predict KRAS Mutation in CRC Patients Using a Machine Learning Algorithm: A Retrospective Study

Porto-Álvarez, J., Cernadas, E., Martínez, R. A., Fernández-Delgado, M., Huelga-Zapico, E., González‐Castro, V., Baleato‐González, S., García‐Figueiras, R., López, J. R. A., & Souto, M. (2023) · Biomedicines · doi:10.3390/biomedicines11082144 · Cited by 23

Ancient Thali Diet: Gut Microbiota, Immunity, and Health.

Shondelmyer, K., Knight, R. D., Sanivarapu, A., Ogino, S., & Vanamala, J. K. P. (2018) · Europe PMC (PubMed Central) · Cited by 23

Serrated neoplasia in the colorectum: gut microbiota and molecular pathways

Kang, X., Zhang, R., Kwong, T. N. Y., Lui, R. N.-S., Wu, W. K. K., Sung, J. J. �., Yu, J. Q., & Wong, S. H. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1863135 · Cited by 23

Fusobacterium nucleatum and Bacteroides fragilis detection in colorectal tumours: Optimal target site and correlation with total bacterial load

Rye, M. S., Garrett, K. L., Holt, R. A., Platell, C. F. E., & McCoy, M. J. (2022) · PLoS ONE · doi:10.1371/journal.pone.0262416 · Cited by 24

Immunomodulation by Gut Microbiome on Gastrointestinal Cancers: Focusing on Colorectal Cancer

AL-Ishaq, R. K., Koklesová, L., Kubatka, P., & Büsselberg, D. (2022) · Cancers · doi:10.3390/cancers14092140 · Cited by 23

Quantitative Proteomic Analysis of Outer Membrane Vesicles from Fusobacterium nucleatum Cultivated in the Mimic Cancer Environment

Zhang, X., Wang, Y., Fan, R., Zhang, L., Li, Z., Zhang, Y., Zheng, W., Wang, L., Liu, B., & Quan, C. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.00394-23 · Cited by 23

Supplementing Synbiotic in Sows' Diets Modifies Beneficially Blood Parameters and Colonic Microbiota Composition and Metabolic Activity in Suckling Piglets

Ma, C., Gao, Q., Zhang, W., Zhu, Q., Tang, W., Blachier, F., Ding, H., & Kong, X. (2020) · Frontiers in Veterinary Science · doi:10.3389/fvets.2020.575685 · Cited by 22

From the Colon to the Liver: How Gut Microbiota May Influence Colorectal Cancer Metastatic Potential

Mignini, I., Piccirilli, G., Galasso, L., Termite, F., Esposto, G., Ainora, M. E., Gasbarrini, A., & Zocco, M. A. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13020420 · Cited by 25

Understanding the Mechanisms of Diet and Outcomes in Colon, Prostate, and Breast Cancer; Malignant Gliomas; and Cancer Patients on Immunotherapy

Mann, S., Sidhu, M., & Gowin, K. L. (2020) · Nutrients · doi:10.3390/nu12082226 · Cited by 21

Microbiome-macrophage crosstalk in the tumor microenvironment: implications for oral squamous cell carcinoma progression and therapy

Deng, X., & Huang, S. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1651837 · Cited by 21

Both the intratumoral immune and microbial microenvironment are linked to recurrence in human colon cancer: results from a prospective, multicenter nodal ultrastaging trial

Noguti, J., Chan, A. A., Bandera, B. C., Brislawn, C., Protić, M., Sim, M., Jansson, J. K., Bilchik, A. J., & Lee, D. J. (2018) · Oncotarget · doi:10.18632/oncotarget.25276 · Cited by 21

Fusobacterium�nucleatum‑positive colorectal cancer (Review)

Yang, Z., & Ji, G. (2019) · Oncology Letters · doi:10.3892/ol.2019.10433 · Cited by 20

The Link between Fusobacteria and Colon Cancer: a Fulminant Example and Review of the Evidence

King, M., Hurley, H., Davidson, K. R., Dempsey, E. C., Barron, M. A., Chan, E. D., & Frey, A. (2020) · Immune Network · doi:10.4110/in.2020.20.e30 · Cited by 21

Microbiota-Derived Natural Products Targeting Cancer Stem Cells: Inside the Gut Pharma Factory

Artusa, V., Calabrone, L., Mortara, L., Peri, F., & Bruno, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054997 · Cited by 22

The microbiota and renal cell carcinoma

Wu, K., Li, Y., Ma, K., Zhao, W., Yao, Z., Zheng, Z., Sun, F., Mu, X., Liu, Z., & Zheng, J. (2023) · Cellular Oncology · doi:10.1007/s13402-023-00876-9 · Cited by 22

Data mining analysis of human gut microbiota links Fusobacterium spp. with colorectal cancer onset

Kharrat, N., Assidi, M., Abu-Elmagd, M. M., Pushparaj, P. N., Alkhaldy, A. A., Arfaoui, L., Naseer, M. I., Omri, A. E., Messaoudi, S. A., Buhmeida, A. S., et al. (2019) · Bioinformation · doi:10.6026/97320630015372 · Cited by 23

Clinicopathological features of sporadic MSI colorectal cancer and Lynch syndrome: a single-center retrospective cohort study

Nakayama, Y., Iijima, T., Inokuchi, T., Kojika, E., Takao, M., Takao, A., Koizumi, K., Horiguchi, S., Hishima, T., & Yamaguchi, T. (2021) · International Journal of Clinical Oncology · doi:10.1007/s10147-021-01968-y · Cited by 20

Combined activity of COX-1 and COX-2 is increased in non-neoplastic colonic mucosa from colorectal neoplasia patients

Jensen, T. S. R., Mahmood, B., Damm, M. M. B., Backe, M. B., Dahllöf, M. S., Poulsen, S. S., Hansen, M. B., & Bindslev, N. (2018) · BMC Gastroenterology · doi:10.1186/s12876-018-0759-1 · Cited by 20

Update and review of the gerodontology prospective for 2020's: Linking the interactions of oral (hypo)-functions to health vs. systemic diseases

Liu, Y. C. G., Lan, S., Hirano, H., Lin, L.-M., Hori, K., Lin, C., Zwetchkenbaum, S. R., Minakuchi, S., & Teng, A. Y. (2020) · Journal of Dental Sciences · doi:10.1016/j.jds.2020.09.007 · Cited by 20

Probiotics Exert Gut Immunomodulatory Effects by Regulating the Expression of Host miRNAs

Li, W., Zeng, Y., Zhong, J., Hu, Y., Xiong, X., Zhou, Y., & Li, F. (2025) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-024-10443-9 · Cited by 21

Gut microbiota in cancer initiation, development and therapy

Zhang, R., Zhang, X., Lau, H. C.-H., & Yu, J. Q. (2024) · Science China Life Sciences · doi:10.1007/s11427-024-2831-x · Cited by 19

Role and potential clinical utility of ARID1A in gastrointestinal malignancy

Wang, R., Chen, M., Ye, X., & Poon, K. (2020) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2020.108360 · Cited by 20

Effects of Saccharomyces cerevisiae var. boulardii on growth, incidence of diarrhea, serum immunoglobulins, and rectal microbiota of suckling dairy calves

Lu, Q., Niu, J., Wu, Y., & Zhang, W. (2022) · Livestock Science · doi:10.1016/j.livsci.2022.104875 · Cited by 20

Immuno-oncology-microbiome axis of gastrointestinal malignancy

Lin, Q., Guan, S.-W., & Yu, H. (2023) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v15.i5.757 · Cited by 20

The next bastion to be conquered in immunotherapy: microsatellite stable colorectal cancer

Ding, K., Mou, P., Wang, Z., Liu, S., Liu, J., Lü, H., & Yu, G. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1298524 · Cited by 19

The Role of the Intestinal Microbiome on Colorectal Cancer Pathogenesis and its Recurrence Following Surgery

Vigneswaran, J., & Shogan, B. D. (2020) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-020-04694-4 · Cited by 20

Association of Fusobacterium nucleatum infection and colorectal cancer: A Mexican study

Cuellar‐Gomez, H., Ocharan-Hernández, M. E., Calzada‐Mendoza, C. C., & Comoto-Santacruz, D. A. (2021) · Revista de Gastroenterología de México (English Edition) · doi:10.1016/j.rgmxen.2021.07.001 · Cited by 22

Fusobacterium nucleatum Enrichment in Colorectal Tumor Tissue: Associations With Tumor Characteristics and Survival Outcomes

Phipps, A. I., Hill, C. M., Lin, G. I., Malen, R. C., Reedy, A. M., Kahsai, O. J., Ammar, H., Curtis, K. R., Ma, N., Randolph, T. W., et al. (2025) · Gastro Hep Advances · doi:10.1016/j.gastha.2025.100644 · Cited by 19

Dietary Patterns and Associated Microbiome Changes that Promote Oncogenesis

Ibragimova, S., Ramachandran, R., Ali, F. R., Lipovich, L., & Ho, S. B. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.725821 · Cited by 18

Location and condition based reconstruction of colon cancer microbiome from human RNA sequencing data

Sambruni, G., Macandog, A. D. G., Wirbel, J., Cagnina, D., Catozzi, C., Dallavilla, T., Borgo, F., Fazio, N., Romario, U. F., Petz, W. L., et al. (2023) · Genome Medicine · doi:10.1186/s13073-023-01180-9 · Cited by 19

Strain-level detection of Fusobacterium nucleatum in colorectal cancer specimens by targeting the CRISPR–Cas region

Shimomura, Y., Sugi, Y., Kume, A., Tanaka, W., Yoshihara, T., Matsuura, T., Komiya, Y., Ogata, Y., Suda, W., Hattori, M., et al. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.05123-22 · Cited by 16

Fusobacterium nucleatum: a novel regulator of antitumor immune checkpoint blockade therapy in colorectal cancer

Luo, M. (2024) · American Journal of Cancer Research · doi:10.62347/myza2640 · Cited by 19

Role of bioactive lipofishins in prevention of inflammation and colon cancer

Lombardi, V., Carrera, I., Corzo, L., & Cacabelos, R. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.11.012 · Cited by 18

Genome-wide prediction and prioritization of human aging genes by data fusion: a machine learning approach

Arabfard, M., Ohadi, M., Tabar, V. R., Delbari, A., & Kavousi, K. (2019) · BMC Genomics · doi:10.1186/s12864-019-6140-0 · Cited by 18

Comparison of the fecal microbiomes of healthy and diarrheic captive wild boar

Bi, W., Deng, B., Yong, F., Zhou, H., Qu, C., & Zhou, Z. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104377 · Cited by 18

The association between Fusobacterium nucleatum and cancer colorectal: A systematic review and meta-analysis

Villar-Ortega, P., Ruíz, M. E., Gutiérrez-Soto, M., Jiménez, M. R.-C., Navarro‐Marí, J. M., & Fernández, J. G. (2022) · Enfermedades infecciosas y microbiologia clinica (English ed ) · doi:10.1016/j.eimce.2022.02.007 · Cited by 17

Relationship Between Intestinal Microorganisms and T Lymphocytes In Colorectal Cancer

Han, S., Xi, Y., Quan, Q., Pan, Y., Da, M., & Zhou, Q. (2019) · Future Oncology · doi:10.2217/fon-2018-0595 · Cited by 16

The interplay between dietary factors, gut microbiome and colorectal cancer: a new era of colorectal cancer prevention

Seesaha, P. K., Chen, X., Wu, X., Xu, H., Li, C., Jheengut, Y., Zhao, F., Liu, L., & Zhang, D. (2020) · Future Oncology · doi:10.2217/fon-2019-0552 · Cited by 20

Impacts of feeding organic acid-based feed additives on diarrhea, performance, and fecal microbiome characteristics of pigs after weaning challenged with an enterotoxigenic strain of Escherichia coli

Pluske, J. R., Turpin, D. L., Sahibzada, S., Pineda, L., Han, Y., & Collins, A. M. (2021) · Translational Animal Science · doi:10.1093/tas/txab212 · Cited by 15

Abstract 4560: Fusobacterium nucleatum and tumor immunity status according to microsatellite instability in colorectal cancer

Mima, K., Hamada, T., Nishihara, R., Nowak, J. A., Qian, Z. R., Kosumi, K., Giannakis, M., Bullman, S., Baba, H., Huttenhower, C., et al. (2017) · Cancer Research · doi:10.1158/1538-7445.am2017-4560

Fusobacterium nucleatum in Colorectal Cancer Relates to Immune Response Differentially by Tumor Microsatellite Instability Status

Hamada, T., Zhang, X., Mima, K., Bullman, S., Sukawa, Y., Nowak, J. A., Kosumi, K., Masugi, Y., Twombly, T. S., Cao, Y., et al. (2018) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0174 · Cited by 237

Fusobacterium nucleatum and T Cells in Colorectal Carcinoma

Mima, K., Sukawa, Y., Nishihara, R., Qian, Z. R., Yamauchi, M., Inamura, K., Kim, S. A., Masuda, A., Nowak, J. A., Nosho, K., et al. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.1377 · Cited by 669

Association of Fusobacterium nucleatum with Specific T-cell Subsets in the Colorectal Carcinoma Microenvironment

Borowsky, J., Haruki, K., Lau, M. C., Costa, A. D., Väyrynen, J. P., Ugai, T., Arima, K., da Silva, A., Felt, K. D., Zhao, M. M., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-4009 · Cited by 110

Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis

Mima, K., Nishihara, R., Qian, Z. R., Cao, Y., Sukawa, Y., Nowak, J. A., Yang, J., Dou, R., Masugi, Y., Song, M., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-310101 · Cited by 1,080